Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
receiving chemotherapy were investigated at National Cancer Institute, Egypt. These patients were subjected to clinical evaluation, chest CT scan, conventional blood cultures for bacterial and fungal pathogens, aspergillus GM antigen detection and PCR assay utilizing pan-fungal primers. Results: Of the 91 FN episodes, 15 were proven IFI; whereas 27 cases were either probable (n= 13) or possible IFI (n= 14), and 49 were unlikely to be IFI episodes. Based on positive results for proven/probable IFI and compared to culture results, Pan-fungal PCR showed sensitivity, specificity, positive and negative predictive values of 75%, 92%, 84% and 87%; respectively. Aspergillus antigen test showed a sensitivity of 79%, specificity of 61%, positive and negative predictive values of 54% and 83%; respectively. A negative PCR in the proven and probable cases was closely related to previous antifungal therapy for a rior history of IFI.Conclusions: In patients at high risk for IFI, the results of PCR assay correlated well with the diagnosis of IFI. The PCR test is more specific than the GM test for screening high risk group cancer patients in a hospital laboratory. The specificity of GM test is not sufficient and can be improved by PCR. The PCR assay seems more promising than the GM test for objectively defining IFI. The main value of the simultaneous use of these tests is to confirm the diagnosis. Therefore, when positive, these tests could provide an alternative to invasive investigations such as lung biopsy Keywords Invasive fungal infection IFI; Haemato-oncology patients; Polymerase ahain reaction PCR; Galactomannan GM; Aspergillus antigen. ISSN : 0743-684X Impact Factor : 0.55 Journal : Reconstructive Microsurgery 22 No 2 97-104 (2006) Free Anterolateral Thigh Flap for Reconstruction of Major Craniofacial Defects Ayman Amin, M.D. , Mohammed Rifaat, M.D., FRCS , Francisco Civantos, M.D. , Donald Weed, M.D. , Mohammed Abu-Sedira, M.D. and Mahmoud Bassiouny, M.D. Abstract : Free-tissue transfer has revolutionized skull-base surgery by expanding the ability to perform cranial base resection and by improving the quality of reconstruction. The anterolateral thigh flap has come recently into use in the field of head and neck reconstruction. Its role in craniofacial and midface reconstruction has not been specifically defined. This study involved a total of 18 patients who were treated over a 5-year period from 1998 to 2003. Seventeen patients had locally advanced head and neck cancer, requiring craniofacial resection, and one patient had a complicated gun shot wound of the forehead. Thirteen patients were treated at the National Cancer Institute, Cairo University, Egypt, and five patients at the University of Miami, Florida. The patients presented with defects of the anterior skull base (5), lateral skull base (3), scalp and calvarium (3), and the midface (7). The anterolateral thigh flap was used as a myocutaneous flap in 11 cases and as a perforator fasciocutaneous flap in seven cases. Musculocutaneous perforators supplied the majority of flaps (17/18). Total flap survival occurred in 17 cases; one patient developed complete flap necrosis. The most commonly used reciepient vessels were the facial vessels and the external jugular vein. Major complications included one case with meningitis; the patient died after failure of treatment. Another patient died 6 weeks postoperatively from pulmonary embolism. One patient developed CSF leak that stopped spontaneously. In addition, two patients developed minor wound dehiscence that healed spontaneously. The donor-site wound healed without problems except in two